Value Aligned Research Advisors’s Lam Research LRCX Stock Holding History

Value Aligned Research Advisors’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.7M	Sell	121,597 -978,959	-89%	-$297M	0.13%	76
2026 Q1	$235M	Buy	1,100,556 +393,523	+56%	+$88M	1.14%	25
2025 Q4	$121M	Buy	707,033 +206,170	+41%	+$32.1M	1.22%	26
2025 Q3	$67.1M	Buy	500,863 +18,533	+4%	+$1.96M	0.82%	31
2025 Q2	$47M	Buy	482,330 +460,816	+2,142%	+$36.5M	0.99%	28
2025 Q1	$1.56M	Buy	+21,514	New	+$1.69M	0.11%	38
2024 Q4	–	Sell	-506,140	Closed	-$41.3M	–	52
2024 Q3	$41.3M	Sell	506,140 -41,800	-8%	-$3.63M	10.73%	5
2024 Q2	$58.3M	Buy	547,940 +1,630	+0.3%	+$156K	12.78%	2
2024 Q1	$53.1M	Sell	546,310 -49,400	-8%	-$4.35M	10.47%	3
2023 Q4	$46.7M	Sell	595,710 -68,530	-10%	-$4.67M	11.79%	2
2023 Q3	$41.6M	Buy	664,240 +32,420	+5%	+$2.13M	13.12%	1
2023 Q2	$40.6M	Buy	631,820 +500,830	+382%	+$28.2M	12.7%	1
2023 Q1	$6.94M	Hold	130,990	–	–	2.46%	13
2022 Q4	$5.51M	Buy	+130,990	New	+$5.48M	2.5%	14

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Value Aligned Research Advisors's LRCX Position: Q2 2026 in Review

Value Aligned Research Advisors reduced its Lam Research (LRCX) stake by 89% in Q2 2026, selling an estimated $297M and leaving 121,597 shares worth $52.7M. The position accounts for 0.13% of the portfolio, ranked #76.

Value Aligned Research Advisors first reported a position in LRCX in Q4 2022 and has held it in 14 quarters since. The position peaked at $235M in Q1 2026. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Value Aligned Research Advisors held 121,597 shares of Lam Research worth $52.7M as of Q2 2026.
Value Aligned Research Advisors sold 978,959 Lam Research shares in Q2 2026, an estimated $297M.
Lam Research made up 0.13% of Value Aligned Research Advisors's portfolio in Q2 2026, its #76 holding.
Value Aligned Research Advisors first reported a position in Lam Research in Q4 2022 and has held it in 14 quarters since.
Value Aligned Research Advisors's Lam Research position peaked at $235M in Q1 2026.
3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Value Aligned Research Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.